The impact of dexamethasone as a perineural additive to ropivacaine for PECS II blockade in patients undergoing unilateral radical mastectomy – A prospective, randomized, controlled and double-blinded trial
Elisabeth Hoerner(Innsbruck Medical University), Guenther Putz(Innsbruck Medical University), Vitaliy Pustilnik(Innsbruck Medical University), Christine Brunner(Innsbruck Medical University), Sabrina Neururer(Innsbruck Medical University), Lukas Gasteiger(Innsbruck Medical University), Daniel Egle(Innsbruck Medical University), Michael Ortler(Innsbruck Medical University), Andreas Schlager(Innsbruck Medical University), Simon Mathis(Innsbruck Medical University)
Cited by 15
Related Papers
Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study
|The Lancet Oncology|2021|255
Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations
|Journal of Allergy and Clinical Immunology|2021|175
Pathological Complete Response to Neoadjuvant Trastuzumab Is Dependent on HER2/CEP17 Ratio in HER2-Amplified Early Breast Cancer
|Clinical Cancer Research|2017|61